2024 -
now Chief Science Officer, Signature Discovery UK @
2017 -
now Director and Co-Founder @
2020 -
2023 VP Chemistry and IP @
2006 -
2022 Editor, Progress in Medicinal Chemistry @
2021 -
2021 Chair Of The Board Of Trustees (interim) @
2014 -
2017 Director of Chemistry and Head of Operations @ Convergence Pharmaceuticals
2010 -
2013 Principal Chemist and Operations Manager @ Convergence Pharmaceuticals
1998 -
2010 Programme leader @
2007 -
2008 Leader, Chemical Biology, Lead Discovery and New Tech. group @
2006 -
2007 Manager, Medicinal Chemistry IT Strategy @
1992 -
2005 Medicinal Chemist @
1992 -
2000 Senior Investigator @
1990 -
1992 Fulbright Scholar and JRF @
David Witty Education
University of Oxford
Doctor Of Philosophy (Chemistry)
1983
-
1990
David Witty Skills
Drug Discovery
Chemistry
Neuroscience
Pain
Organic Chemistry
Medicinal Chemistry
Pharmaceuticals
Science
Laboratory
Organic Synthesis
Technology Transfer
Cheminformatics
Pharmaceutical Industry
Drug Development
Pharmaceutics
CRO
Pain Management
LC-MS
Pharmaceutical Research
R&D
Customer Service
Marketing
Chemical Engineering
Entrepreneurship
Management
Strategy
Lc Ms
Startups
David Witty Summary
David Witty, based in United Kingdom, is currently a Chief Science Officer, Signature Discovery UK at Sygnature Discovery. David Witty brings experience from previous roles at WITNET LTD, Eliem Therapeutics (UK) Ltd, Elsevier and Society of Chemical Industry. David Witty holds a 1983 - 1990 Doctor Of Philosophy in Chemistry @ University of Oxford. With a robust skill set that includes Drug Discovery, Chemistry, Neuroscience, Pain, Organic Chemistry and more. David Witty has 2 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.